News
Cosmos Holdings, Inc. Announces Year End 2018 Financial Results
CHICAGO, April 23, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced its full-year 2018 financial results for the year ended December 31, 2018. 2018 Highlights: - Revenue improved 23.6% to $37 million from $30 million in 2017 - Gross profit increase 23.1% to $2.4 million from $1.96 million in 2017 - Operating expenses decreased by 46.7% year over year. - Repaid the remaining balance of its convertible notes, totaling $5.5 million. - Completed the acquisition of Cosmofarm Ltd., ...
Cosmos Holdings, Inc. Adds to Its Advisory Board
CHICAGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added executive Vassos Efthymiadis to its advisory board. Mr. Efthymiadis is the Managing Director of K&N Efthymiadis S.A. and Vice President of the Redestos Agrotechnology Group, both companies are leaders in agribusiness in Greece. Mr. Efthymiadis is also President of the Hellenic Crop Protection Association, Board Member of the Hellenic Association of Chemical Industries, and Advisory ...
Cosmos Holdings, Inc. Pays Off All Convertible Debt
CHICAGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (OTCQB: COSM), an international pharmaceutical company, announced today that it paid off the remaining balance of its convertible notes. The aggregate initial principal amounts of the notes totaled $5,583,333. Cosmos Holdings CEO Gregory Siokas commented, “We are excited to announce the repayment of all our convertible debt. With the acquisition of Cosmofarm that closed in December of last year, and this note repayment, we believe are well-positioned for growth ...
Cosmos Holdings, Inc. Adds Distinguished Portfolio Manager With Mid-Cap & Large-Cap Value Expertise to Its Advisory Board
CHICAGO, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has added Tom Kolefas to its Advisory Board. Kolefas brings more than 25 years of Wall Street experience on the buyside - managing both mutual fund and institutional equities at TIAA Investments, Jennison Associates, Loomis Sayles, Mackay-Shields and Bank of New York; as well as industry experience as a chemical engineer and corporate development officer at Engelhard/BASF. The Company ...
Cosmos Holdings, Inc. Acquires Cosmofarm Ltd.
Cosmos Holdings acquires Cosmofarm Cosmos Holdings, Inc. (OTCQB: COSM) announced the closing of its acquisition of Cosmofarm Ltd, a privately held fully licensed pharmaceutical wholesale company located in Athens, Greece. Founded in 1994, Cosmofarm is a fully licensed pharmaceutical wholesale company operating in the greater Athens area. The company is approved and authorized by the National Organization for Medicines under Good Distribution Practices to distribute a comprehensive range of pharmaceutical products. Cosmofarm’s core activity is sourcing, procuring and distributing branded and generic ...
Photo
Steve Carr Managing Director

Join our mailing list to stay up to date.

Cosmos-logo